WESTBURY, N.Y., April 1, 2013 /PRNewswire/ — Vasomedical, Inc. (“Vasomedical”) (OTC BB: VASO) today reported its operating results for the three months and year ended December 31, 2012. “This year we saw an increase in activity across each of our business segments, even though not everything was reflected in our total revenue for 2012, which declined...
Read More

WESTBURY, N...Y..., April 1, 2013 /PRNewswire/ — Vasomedical, Inc... (OTC BB: VASO), announced today that its Board of Directors has authorized a share repurchase program of up to $1...5 million of the Company’s common stock... As of Friday, March 29, 2013, this would represent approximately 5% of the total outstanding shares of Vasomedical common stock...
Read More

WESTBURY... N.Y.... March 25... 2013 /PRNewswire/ — Vasomedical... Inc. (OTC BB: VASO)... announced today that it will release its financial results for the three months and year ended December 31... 2012 on Monday... April 1... 2013. The Company will host a conference call on Monday... April 1st at 1:00 p.m. ET featuring remarks by Jun Ma...
Read More

WESTBURY, N.Y., Dec. 10, 2012 /PRNewswire/ — Vasomedical, Inc. (“Vasomedical” or the “Company”) (OTCBB: VASO) announced today that its shares of common stock have initiated trading via the Over-the-Counter Bulletin Board (OTCBB) under the ticker symbol “VASO”. The listing of the Company’s common stock on the OTCBB follows FINRA’s approval on December 3, 2012 of a 15c2-11...
Read More

WESTBURY... N.Y.... Nov. 27... 2012 /PRNewswire/ — On November 19... The American College of Cardiology Foundation and American Heart Association (ACCF/AHA) Task Force on Practice Guidelines issued its new Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease.  Enhanced external counterpulsation... or EECP®Therapy... a proprietary non-invasive cardiology treatment patented by Vasomedical... Inc....
Read More